نمایش پرونده ساده آیتم

dc.contributor.authorMolaie, S
dc.contributor.authorMohebali, M
dc.contributor.authorAbai, M-R
dc.contributor.authorMolaie, A
dc.contributor.authorAkhoundi, B
dc.contributor.authorAsl, EM
dc.date.accessioned2018-08-26T08:33:43Z
dc.date.available2018-08-26T08:33:43Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52465
dc.description.abstractThe early diagnosis of visceral leishmaniasis (VL) using Direct Agglutination Tests (DAT) and its treatment and control are essential actions taken in rural health centers in endemic foci of the infection based on the national protocols set by the Iranian Ministry of Health and Medical Education. Eleven clinically confirmed VL patients with typical VL symptoms and negative results of DAT, admitted to the pediatrics department of Valiasr Hospital in Meshkinshahr underwent parasitological tests. 7 of the total of 11 patients had positive result of bone marrow puncture smears and all of them had negative results of DAT. Thus factors that had led to false negative DAT results were examined. The patients' blood samples were collected in microhematocrit tubes using the finger prick technique, centrifuged and their plasma then separated. The complete medical history of the patients was taken using a questionnaire. The laboratory staff therefore checked the quality of anti-leishmania antigen, materials and equipment used. The patients' medical history showed that they had all been administered corticosteroid medications such as dexamethasone or hydrocortisone prior to visiting the laboratory. The DAT was repeated in these patients 2-3آ weeks after their last administration of corticosteroids. The antibody titers were positive this time. A total of 3 of the collected specimens (27.3آ %) showed a titer of 1.3200, 5 (46آ %) showed a titer of 1.1600 and 3 (27.3آ %) a titer of 1.800. Due to the effects of some medications, particularly corticosteroids, on serological tests, the patients' full medical history should be taken prior to performing this test and physicians working at endemic regions of this infection should be notified about these drug interactions. é 2016, Indian Society for Parasitology.
dc.language.isoEnglish
dc.relation.ispartofJournal of Parasitic Diseases
dc.subjectdexamethasone
dc.subjecthydrocortisone
dc.subjectagglutination test
dc.subjectanorexia
dc.subjectantibody titer
dc.subjectArticle
dc.subjectblood sampling
dc.subjectbone marrow biopsy
dc.subjectchild
dc.subjectclinical article
dc.subjectdiarrhea
dc.subjectfemale
dc.subjectfever
dc.subjecthuman
dc.subjectIranian (citizen)
dc.subjectmalaise
dc.subjectmale
dc.subjectpreschool child
dc.subjectpriority journal
dc.subjectquestionnaire
dc.subjectvisceral leishmaniasis
dc.titleAlteration of Direct Agglutination Test (DAT) results in Iranian Kala-Azar patients: a case series
dc.typeLetter
dc.citation.volume41
dc.citation.issue2
dc.citation.spage446
dc.citation.epage449
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1007/s12639-016-0825-y


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم